MedTrace Logo

A Retrospective Analysis of Suramin Treatment for Stage 1 TBR

NCT06060600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 345

Last updated 2023-09-29

No results posted yet for this study

Summary

The study will include TBR HAT patients treated with suramin between 2000 and 2020 at three sites in Uganda and Malawi A natural history cohort composed of source data from approximately 200 patients from a published epidemiological study will be used as a comparator.

This study's objectives are to evaluate the efficacy and safety of suramin in the Stage 1 treatment of TBR HAT.

Conditions

  • Trypanosoma Brucei Rhodesiense; Infection

Sponsors & Collaborators

  • Paxmedica

    lead INDUSTRY

Principal Investigators

  • jennifer L bonfrisco · Paxmedica

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2023-08-02
Completion
2023-08-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06060600 on ClinicalTrials.gov